- Filed
- Mar 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Mar 12, 2026 | 17.93M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 17.39M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 16.83M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 12.45M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 12.22M sh |
| Capex | Q2 2026 · Jan 31, 2026 | $0 |
| Capex | Q2 2026 · Jan 31, 2025 | $13K |
| Operating Cash Flow | Q2 2026 · Jan 31, 2026 | −$39.77K |
| Operating Cash Flow | Q2 2026 · Jan 31, 2025 | −$415.35K |
| Stockholders Equity | Q2 2026 · Jan 31, 2026 | −$7.28K |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | $4.47K |
| Current Liabilities | Q2 2026 · Jan 31, 2026 | $56.56K |
| Current Liabilities | Q2 2026 · Jul 31, 2025 | $38.34K |
| Total Liabilities | Q2 2026 · Jan 31, 2026 | $406.56K |
| Total Liabilities | Q2 2026 · Jul 31, 2025 | $38.34K |
| Current Assets | Q2 2026 · Jan 31, 2026 | $49.29K |
| Current Assets | Q2 2026 · Jul 31, 2025 | $42.81K |
| Total Assets | Q2 2026 · Jan 31, 2026 | $399.29K |
| Total Assets | Q2 2026 · Jul 31, 2025 | $42.81K |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $0.00 |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | −$0.01 |
| Eps Diluted | Q2 2026 · Jan 31, 2025 | −$0.01 |
| Eps Diluted | Q2 2026 · Jan 31, 2025 | −$0.01 |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $1.46K |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $3.05K |
| Sga Expense restated | Q2 2026 · Jan 31, 2025 | $588 |
| Sga Expense restated | Q2 2026 · Jan 31, 2025 | $678 |
| Net Income | Q2 2026 · Jan 31, 2026 | −$62.11K |
| Net Income | Q2 2026 · Jan 31, 2026 | −$94.24K |
| Net Income | Q2 2026 · Oct 31, 2025 | −$32.14K |
| Net Income restated | Q2 2026 · Jan 31, 2025 | −$78.3K |
| Net Income restated | Q2 2026 · Jan 31, 2025 | −$152.78K |
| Net Income | Q2 2026 · Oct 31, 2024 | −$74.49K |
| Operating Income | Q2 2026 · Jan 31, 2026 | −$53.61K |
| Operating Income | Q2 2026 · Jan 31, 2026 | −$85.75K |
| Operating Income restated | Q2 2026 · Jan 31, 2025 | −$39.44K |
| Operating Income restated | Q2 2026 · Jan 31, 2025 | −$77.26K |
| Revenue | Q2 2026 · Jan 31, 2026 | $0 |
| Revenue | Q2 2026 · Jan 31, 2026 | $0 |
| Revenue restated | Q2 2026 · Jan 31, 2025 | $0 |
| Revenue restated | Q2 2026 · Jan 31, 2025 | $0 |
| Dividends Paid | Q2 2026 · Jul 8, 2025 | $35.62K |